Safety Profile Cagrilintide has been studied in multiple Phase 2 and Phase 3 trials involving thousands of participants
Products containing BPC-157 might be labeled as research chemicals and carry statements such as Not for human consumption, Research use only, or For research purposes only. Service Members should avoid using research chemicals or any products containing prohibited ingredients, regardless of how they are taken (by mouth, injection, or nasal spray)
Biohacking culture, anti-aging obsession, GLP-1 popularity, and social media have amplified interest
In July 2026, an FDA advisory committee (the Pharmacy Compounding Advisory Committee, or PCAC) voted to recommend that several peptides including BPC-157, TB-500, KPV, and MOTS-c be considered for inclusion on the 503A compounding list
However, if it's nearly time for your next dose, skip the missed one and continue with your regular schedule